Evergrande Health Industry : (1) PROPOSED CHANGE OF COMPANY NAME; AND (2) CLOSURE OF REGISTER OF MEMBERS

THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this circular, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this circular.

If you are in any doubt as to this circular or as to the action to be taken, you should consult your stockbroker or other registered dealer in securities, bank manager, solicitor, professional accountant or other professional adviser.

If you have sold or transferred all your shares in Evergrande Health Industry Group Limited, you should at once hand this circular together with the accompanying form of proxy to the purchaser or transferee or to the bank, the licensed securities dealer or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee.

EVERGRANDE HEALTH INDUSTRY GROUP LIMITED

恒 大 健 康 產 業 集 團 有 限 公 司

(a company incorporated in Hong Kong with limited liability)

(Stock Code: 708)

1. PROPOSED CHANGE OF COMPANY NAME; AND
2. CLOSURE OF REGISTER OF MEMBERS

A notice convening the General Meeting of the Company to be held at Taishan Room, Level 5, Island Shangri-La, Hong Kong, Pacific Place, Supreme Court Road, Central, Hong Kong on Thursday, 20 August 2020 at 11:00 a.m. is set out on pages 9 to 10 of this circular. Whether or not you are able to attend the General Meeting, you are requested to complete and return the accompanying form of proxy in accordance with the instructions printed thereon to the Company's share registrar, Tricor Secretaries Limited at Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong as soon as possible, but in any event not less than 48 hours before the time of the General Meeting (or any adjournment thereof). Completion and return of the form of proxy will not preclude you from attending and voting in person at the General Meeting or adjournment thereof.

MEASURES TAKEN IN LIGHT OF CORONAVIRUS DISEASE 2019

Please see page 3 to 4 of this document for measures being taken to try to prevent and control the spread of the COVID-19 at the General Meeting, including:

. compulsory temperature check and health declaration

. compulsory wearing of surgical face mask throughout the General Meeting

. prohibit attendance at the General Meeting if the attendee has a fever. Persons exhibiting flu-like symptoms may also be refused admittance

. no corporate gifts will be distributed and no refreshments will be served at the General Meeting

Any person who does not comply with the precautionary measures may be denied entry into the General Meeting venue. The Company reminds Shareholders that they may appoint the chairman of the meeting as their proxy to vote on the relevant resolutions at the General Meeting as an alternative to attend the General Meeting in person.

3 August 2020

CONTENTS

	Page
DEFINITIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	1
PRECAUTIONARY MEASURES FOR THE GENERAL MEETING . . . . . . . . . . . . . . . . . . .	3
LETTER FROM THE BOARD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	5
NOTICE OF GENERAL MEETING . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	9

- i -

DEFINITIONS

In this circular, unless the context otherwise requires, the following expressions shall have the following meanings:

''associate(s)''	has the same meaning ascribed to it under the Listing Rules
''Announcement''	the announcement of the Company dated 27 July 2020, in
	relation to, among others, the Proposed Change of Name
''Board''	the board of directors of the Company
''COVID-19''	Coronavirus Disease 2019
''Company''	Evergrande Health Industry Group Limited, a company
	incorporated in Hong Kong with limited liability, the issued
	Shares of which are listed and traded on the Main Board of the
	Hong Kong Stock Exchange (stock code: 708)
''Directors''	the directors of the Company
''General Meeting''	the general meeting of the Company to be held on Thursday,
	20 August 2020 for the purpose of considering and, if thought
	fit, approving the Proposed Change of Name
''Group''	the Company and its subsidiaries
''HKSAR Government''	the Government of Hong Kong
''Hong Kong''	the Hong Kong Special Administrative Region of the People's
	Republic of China
''Latest Practicable Date''	31 July 2020, being the latest practicable date prior to the
	printing of this circular for ascertaining certain data contained
	in this circular
''Listing Rules''	the Rules Governing the Listing of Securities on the Stock
	Exchange
''PRC''	the People's Republic of China which, for the purposes of this
	circular, excludes Hong Kong, the Macau Special
	Administrative Region of the PRC and Taiwan
''Proposed Change of Name''	the proposed change of the name of the Company from
	''Evergrande Health Industry Group Limited 恒大健康產業集
	團有限公司'' to ''China Evergrande New Energy Vehicle
	Group Limited 中國恒大新能源汽車集團有限公司''

- 1 -

DEFINITIONS

''Regulation''	Prevention and Control of Disease (Prohibition on Group
	Gathering) Regulation (Cap. 599G of the Laws of Hong
	Kong), as amended and supplemented from time to time
''Share(s)''	the ordinary share(s) of the Company
''Shareholder(s)''	the holder(s) of Shares
''Stock Exchange''	The Stock Exchange of Hong Kong Limited
''subsidiary(ies)''	has the meaning ascribed to it under the Listing Rules

- 2 -

PRECAUTIONARY MEASURES FOR THE GENERAL MEETING

In view of the ongoing COVID-19 epidemic and recent requirements for prevention and control of its spread (as per guidelines issued by the HKSAR Government at https:// www.chp.gov.hk/en/features/102742.html), the Company will implement necessary preventive measures at the General Meeting to protect attending Shareholders, proxy and other attendees from the risk of infection, including:

1. Compulsory body temperature check will be conducted on every Shareholder, proxy and other attendees at the entrance of the General Meeting venue. Any person with a body temperature of over 37.2 degrees Celsius may be denied entry into the General Meeting venue or be required to leave the General Meeting venue.
2. Attendees are required to prepare his/her own surgical face masks and wear the same inside the General Meeting venue at all times, and to maintain a safe distance between seats.
3. No corporate gifts will be distributed and no refreshments will be served.

Under item 11 of Schedule 1 to the Regulation, group gatherings of more than 20 persons for shareholders' meetings, at which no food or drink is served, are required to be accommodated in different rooms or partitioned areas of not more than 20 persons each. Having taken into consideration the Regulation, current COVID-19 pandemic situation and the requirement to keep appropriate social distancing for the health and safety of the Shareholders and other attendees of General Meeting, seats at the General Meeting venue will be arranged to allow for appropriate physical distancing. As a result, there will be limited capacity at the General Meeting venue to accommodate only up to 20 persons. Shareholders in excess of the limited capacity of the General Meeting venue will not be admitted to the General Meeting venue. Given the limited capacity of the General Meeting venue and the requirements for social distancing to ensure the health and safety of the attendees of the General Meeting, only Shareholders (or their proxies), Directors and relevant General Meeting supporting staff will be allowed entry into the General Meeting venue.

Shareholders are reminded (i) to consider carefully the risk of attending the General Meeting, which will be held in an enclosed environment; (ii) to follow any guidelines or requirements of HKSAR Government relating to COVID-19 pandemic in deciding whether or not to attend the General Meeting; and (iii) not to attend the General Meeting if they have contracted or are suspected to have contracted COVID-19. Shareholders attending the General Meeting in person are expected to comply with all precautionary measures as set out in this circular. Any person who declines to adhere to any of the measures or cooperate with the hotel or Company staff, or is subject to any prescribed quarantine of the HKSAR Government may be denied entry into the General Meeting Venue or be required to leave the General Meeting venue at the absolute discretion of the Company as permitted by law.

In the interest of all attendees' health and safety, the Company wishes to advise all Shareholders that physical attendance in person at the General Meeting is not necessary for the purpose of exercising voting rights. As an alternative, by using proxy forms with voting

- 3 -

PRECAUTIONARY MEASURES FOR THE GENERAL MEETING

instructions duly completed, Shareholders may appoint the Chairman of the General Meeting as their proxy to vote on the relevant resolutions at the General Meeting instead of attending the General Meeting in person.

The proxy form is enclosed to this circular. If you are not a registered Shareholder (i.e., if your Shares are held via banks, brokers, custodians or Hong Kong Securities Clearing Company Limited), you should consult directly with your banks or brokers or custodians (as the case may be) to assist you in the appointment of proxy.

- 4 -

LETTER FROM THE BOARD

EVERGRANDE HEALTH INDUSTRY GROUP LIMITED

恒 大 健 康 產 業 集 團 有 限 公 司

(a company incorporated in Hong Kong with limited liability)

	(Stock Code: 708)
Executive Directors:	Registered Office:
Mr. Shi Shouming (Chairman)	23rd Floor, China Evergrande Centre
Mr. Liu Yongzhuo (Vice-chairman)	38 Gloucester Road
Mr. Qin Liyong	Wanchai
	Hong Kong
Independent Non-executive Directors:
Mr. Chau Shing Yim, David	Share Registrar:
Mr. Guo Jianwen	Tricor Secretaries Limited
Mr. Xie Wu	Level 54, Hopewell Centre
	183 Queen's Road East
	Hong Kong
	3 August 2020
To the Shareholders
Dear Sir/Madam,

1. PROPOSED CHANGE OF COMPANY NAME AND
2. CLOSURE OF REGISTER OF MEMBERS

INTRODUCTION

Reference is made to the Announcement in relation to, among other things, the Proposed Change of Name.

The purpose of this circular is to provide the Shareholders with (i) information in respect of the Proposed Change of Name; and (ii) a notice of General Meeting.

PROPOSED CHANGE OF COMPANY NAME

The Board has proposed to change the name of the Company from ''Evergrande Health Industry Group Limited 恒大健康產業集團有限公司'' to ''China Evergrande New Energy Vehicle Group Limited 中國恒大新能源汽車集團有限公司''.

- 5 -

LETTER FROM THE BOARD

Reasons for the Proposed Change of Name

The Group is developing its new energy vehicle business in full speed and has built a new energy vehicle industry chain covering power battery, motor powertrain, advanced vehicle manufacturing, vehicle sales and smart charging. The Group is also equipped with world-leading core technologies in key aspects and has implemented a global integrated research and development model to coordinate research and development works in China, Sweden, Germany, the United Kingdom, the Netherlands, Austria, Italy, Japan, South Korea and other countries. The Group strives to become the world's largest and most powerful new energy vehicle group within 3-5 years.

As the new energy vehicle has become the most important business of the Group, the Board proposes to change the name of the Company to ''中國恒大新能源汽車集團有限公司 China Evergrande New Energy Vehicle Group Limited'' and the Company may simply be referred to as ''Evergrande Auto''. The Board is of the view that the Proposed Change of Name is in the interests of the Company and the Shareholders as a whole.

Conditions of the Proposed Change of Name

The Proposed Change of Name is subject to satisfaction of the following conditions:

1. the passing of the necessary special resolution by the Shareholders at the General Meeting to approve the Proposed Change of Name; and
2. the Registrar of Companies of Hong Kong approving the change of name of the Company.

Subject to the satisfaction of the conditions set out above, the Proposed Change of Name will take effect upon the date of the issue of a ''Certificate of Change of Name'' of the Company by the Registrar of Companies of Hong Kong confirming that the new name has been registered.

Effect of the Proposed Change of Name

The Proposed Change of Name will not affect any of the rights of the Shareholders. All existing share certificates in issue bearing the current name of the Company will continue to be evidence of title to the Shares under the new name and will not require replacement as a result of the change of name becoming effective and will be valid for trading, settlement and registration purposes. There will not be any arrangement for exchange of the existing certificates of securities for new certificates bearing the new name of the Company.

Once the Proposed Change of Name becomes effective, new certificates evidencing securities will be issued only in the new name of the Company. Subject to the confirmation by the Stock Exchange, the Chinese and English stock short names of the Company for trading in the securities on the Stock Exchange will also be changed after the Proposed Change of Name becoming effective. Further announcement(s) will be made by the Company to inform the Shareholders of,

- 6 -

LETTER FROM THE BOARD

among other things, the results of the General Meeting, the effective date of the Proposed Change of Name and the new stock short names of the Company for trading of the Shares on the Stock Exchange as and when appropriate.

GENERAL MEETING

The General Meeting will be convened for the purpose of considering and, if thought fit, approving the Proposed Change of Name.

As none of the Directors had a material interest in the Proposed Change of Name, no Director has abstained from voting on the relevant board resolutions of the Company.

In accordance with the Listing Rules, the proposed resolution in relation to the Proposed Change of Name shall be passed by way of poll as a special resolution. To the best of the Directors' knowledge, information and belief having made all reasonable enquiries, as at the Latest Practicable Date, none of the Shareholders or any of their respective associates has material interest in the Proposed Change of Name. Therefore, none of the Shareholders is required to abstain from voting on the relevant resolution(s) to be proposed at the General Meeting.

You may vote at the General Meeting if you are a Shareholder on Thursday, 20 August 2020, which is referred to in this circular as the record date. Notice of the General Meeting (please refer to page 9 to page 10 of this circular) and the proxy form thereof are enclosed to this circular.

CLOSURE OF THE REGISTER OF MEMBERS OF THE COMPANY

The register of members of the Company will be closed from Monday, 17 August 2020 to Thursday, 20 August 2020 (both dates inclusive) during which period of no transfer of the Shares (as the case may be) will be registered, for the purpose of ascertaining Shareholders' entitlement to attend and vote at the General Meeting.

In order to be entitled to attend and vote at the General Meeting, all transfers of the Shares accompanied with the relevant share certificates and transfer forms must be lodged with the share registrar of the Company, Tricor Secretaries Limited at Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong no later than 4:30 p.m. on Friday, 14 August 2020.

RESPONSIBILITY STATEMENT

This circular, for which the Directors collectively and individually accept full responsibility, includes particulars given in compliance with the Listing Rules for the purpose of giving information with regard to the Company. The Directors, having made all reasonable enquiries, confirm that to the best of their knowledge and belief the information contained in this circular is accurate and complete in all material respects and not misleading or deceptive, and there are no other matters the omission of which would make any statement herein or this circular misleading.

- 7 -

LETTER FROM THE BOARD

RECOMMENDATION

The Directors consider that the Proposed Change of Name is in the best interests of the Company and the Shareholders. Accordingly, the Directors recommend the Shareholders to vote in favour of the relevant resolutions to be proposed at the General Meeting.

Yours faithfully,

By Order of the Board

Evergrande Health Industry Group Limited

Shi Shouming

Chairman

- 8 -

NOTICE OF GENERAL MEETING

EVERGRANDE HEALTH INDUSTRY GROUP LIMITED

恒 大 健 康 產 業 集 團 有 限 公 司

(a company incorporated in Hong Kong with limited liability)

(Stock Code: 708)

NOTICE OF GENERAL MEETING

NOTICE IS HEREBY GIVEN that the general meeting (the ''General Meeting'') of Evergrande Health Industry Group Limited (the ''Company'') will be held at Taishan Room, Level 5, Island Shangri-La, Hong Kong, Pacific Place, Supreme Court Road, Central, Hong Kong on Thursday, 20 August 2020 at 11:00 a.m. for the purpose of considering and, if thought fit, passing the following resolutions of the Company. Terms and expressions that are not expressly defined in this notice of general meeting shall have the same meaning as those defined in the circular to the shareholders of the Company (the ''Shareholders'') dated 3 August 2020.

SPECIAL RESOLUTION

''THAT:

1. subject to the approval of the Registrar of Companies of Hong Kong, the name of the Company be changed to ''China Evergrande New Energy Vehicle Group Limited 中國恒 大新能源汽車集團有限公司''; and
2. any one director of the Company be and is hereby authorized to do all such acts, deeds, and things and execute all documents as he or she considers necessary or desirable to give effect and implement the above change of name of the Company.''

By Order of the Board

Evergrande Health Industry Group Limited

Shi Shouming

Chairman

Hong Kong, 3 August 2020

Notes:

1. A member of the Company entitled to attend and vote at the General Meeting convened by the above notice is entitled to appoint one, or if he/she is a holder of more than one share, or more proxies to attend and vote in his/her stead. A proxy need not be a member of the Company.

- 9 -

NOTICE OF GENERAL MEETING

1. In order to be valid, the form of proxy must be in writing under the hand of the appointor or his/her attorney duly authorized in writing, or if the appointor is a corporation, either under its common seal, or under the hand of an officer or attorney duly authorized on that behalf, and must be deposited at the Company's share registrar, Tricor Secretaries Limited at Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong together with a power of attorney or other authority, if any, under which it is signed or a certified copy of that power of attorney, not less than 48 hours before the time for holding the General Meeting or adjourned meeting.
2. Where there are joint holders of any share, any one of such joint holder may vote, either in person or by proxy in respect of such share as if he/she were solely entitled thereto, but if more than one of such joint holders be present at the General Meeting, the vote of the senior who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the votes of the other joint holders, and, for this purpose, seniority shall be determined by the order in which the names stand in the register in respect of the joint holding of such share.
3. For the purpose of ascertaining Shareholders' right to attend and vote at the above meeting, the register of members of the Company will be closed and the relevant details are set out below:
   Latest time to lodge transfer: 4:30 p.m. on 14 August 2020 (Friday)
   Book closure: 17 August 2020 (Monday) to 20 August 2020 (Thursday)
   Record date: 20 August 2020 (Thursday)
   During the above closure period, no transfer of shares will be registered. In order to qualify for the right to attend and vote at the above meeting, all relevant share certificates and properly completed transfer forms must be lodged for registration with the Company's share registrar, Tricor Secretaries Limited at Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong before the above latest time to lodge transfer.
4. Completion and delivery of the form of proxy will not preclude a member from attending and voting in person at the General Meeting.
5. Pursuant to Rule 13.39(4) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, all resolutions set out in this notice will be decided by poll at the General Meeting. Where the Chairman in good faith, decides to allow a resolution which relates purely to a procedural or administrative matter to be voted, such resolution will be decided by a show of hands.

(vii) If Typhoon	Signal No.	8 or above, or a ''black'' rainstorm warning is in effect any	time after 1:00 p.m.
and before	the above	General Meeting time, the meeting will be postponed. The	Company will post
an announcement on the website of	the Stock Exchange (http://www.hkexnews.hk) and the Company's website
(http://www.evergrandehealth.com) to	notify Shareholders of the date, time and place of the rescheduled meeting.

- 10 -